Dare Bioscience, Inc. Quarterly Operating Income (Loss) in USD from Q2 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Dare Bioscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2016 to Q2 2024.
  • Dare Bioscience, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$7.36M, a 18.1% increase year-over-year.
  • Dare Bioscience, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$26.9M, a 33.9% increase year-over-year.
  • Dare Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$30.9M, a 1.42% increase from 2022.
  • Dare Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$31.4M, a 19.7% increase from 2021.
  • Dare Bioscience, Inc. annual Operating Income (Loss) for 2021 was -$39.1M, a 42.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$26.9M -$7.36M +$1.63M +18.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$28.6M -$6.02M +$2.36M +28.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$30.9M -$5.17M +$11.1M +68.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$42M -$8.4M -$1.26M -17.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$40.7M -$8.99M -$9.37M -2439% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$31.4M -$8.38M +$17.8K +0.21% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$31.4M -$16.2M -$6.69M -70.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$24.7M -$7.14M +$5.53M +43.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$30.2M $384K +$9.55M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$39.8M -$8.4M -$707K -9.19% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$39.1M -$9.54M -$1.1M -13.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$38M -$12.7M -$5.09M -67.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$32.9M -$9.16M -$2.04M -28.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$30.8M -$7.69M -$3.44M -80.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$27.4M -$8.44M -$4.58M -119% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$22.8M -$7.58M -$4.16M -122% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$18.7M -$7.13M -$3.14M -78.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$15.5M -$4.25M -$1.17M -38% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$14.3M -$3.86M -$902K -30.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$13.4M -$3.42M -$797K -30.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$12.6M -$3.98M -$358K -9.87% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$12.3M -$3.08M +$4.59M +59.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$16.9M -$2.96M +$6.18M +67.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$23.1M -$2.62M -$1.29M -96.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$21.8M -$3.62M -$3.15M -656% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$18.6M -$7.68M -$7.45M -3260% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$11.2M -$9.14M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$1.33M +$4.63M +77.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$480K -$112K -30.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$228K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q3 2016 -$5.96M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$368K Apr 3, 2016 Jun 30, 2016 8-K/A 2017-10-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.